期刊文献+

探讨胆汁肿瘤标志物对胆管良恶性疾病的诊断价值 被引量:1

The value of biliary tumor markers for differentiatial diagnosis of benign and malignant biliary disea-ses
原文传递
导出
摘要 目的探讨胆汁肿瘤标志物对胆管良恶性疾病的诊断价值。方法160例因胆道疾病需要ERCP治疗者,ERCP时取胆汁检测胆汁肿瘤标志物(CA19-9、CEA和CA242)和细菌培养。结果恶性狭窄组与良性疾病组间胆汁和血清CA19-9、CEA、CA242水平差异均有统计学意义(P〈0.05);根据ROC曲线制定恶性狭窄的胆汁肿瘤标志物界限值:CA19-9239ku/L,CEA40ng/ml,CA24260ku/ml。CEA敏感度、准确度、阴性预测值与血液标志物比较差异有统计学意义(P〈O.05)。3种胆汁标志物的特异性与血清比较差异无统计学意义。胆管癌、胰腺癌、十二指肠乳头癌与胆管旁转移癌、肝癌比较CA19-9水平差异有统计学意义(P〈0.05);无论是恶性狭窄组还是良性疾病组,细菌阳性胆汁与阴性胆汁组间CA19-9水平比较差异均有统计学意义(P〈0.05)。结论胆汁CA19-9、CEA、CA242水平对鉴别胆道良恶性疾病有一定帮助,但并不明显优于血清标志物。胆汁细菌感染可引起胆汁CA19-9水平升高,但不影响良恶性诊断结果。 Objective To investigate the value of biliary tumor markers for differential diagnosis of the benign and malignant biliary tract diseases. Methods Tumor markers (CAl9-9, CEA and CA242) ex-amination and bacterial culture were performed in a total of 160 patients, who underwent therapeutic endo-scopic retrograde cholangiopancreatography (ERCP) for biliary diseases. Results There were significant differences between malignant group and benign group in bile and serum in the level of CA19-9, CEA and CA242 ( P 〈 0.05 ) ; Cut-off value, according to ROC curve, was 239 ku/1 in CA19-9, 40 ng/ml in CEA and 60 ku/ml in CA242, respectively. There were significant differences between the bile marker and the serum marker in sensitivity, accuracy, negative predicative value of CEA ( P 〈 0.05 ). No significant differences was found in specificity between the serum group and the bile group. There were significant differences in bile CA19-9 level between cholangiocareinoma, pancreatic cancer,duodenal papilla carcinoma with carcino-ma metastasizing to bile duet, and hepatocellular carcinoma ( P 〈 0. 05 ). Both in benign group and malig-nant group, there were significant differences in CA19-9 level between infectious bile and noninfectious bile ( P 〈 0. 05 ). Conclusion The level of CA19-9, CEA and CA242 in bile can be applied to differentiate be- nign and malignant biliary diseases. The bile tumor markers do not have advantage over serum tumor markers in specificity for diagnosis. Bile bacterial infection can result in the elevation of bile CA19-9 while it does not have impact on differential diagnosis.
出处 《中华消化内镜杂志》 2014年第1期22-25,共4页 Chinese Journal of Digestive Endoscopy
关键词 胆管狭窄 良恶性 胆汁 肿瘤标志物 胰胆管造影术 内窥镜逆行 Bile duct stricture Benign and malignant Bile Tumor markers Cholangio-pancreatography, Endoscopic Retrograde
  • 相关文献

参考文献4

二级参考文献313

  • 1Aldo Spadaro,Antonino Ajello,Carmela Morace,Agata Zirilli,Graziella D'arrigo,Carmelo Luigiano,Francesco Martino,Anna Bene,Domenico Migliorato,Santi Turiano,Oscar Ferraù,Maria Antonietta Freni.Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits[J].World Journal of Gastroenterology,2005,11(13):1987-1990. 被引量:4
  • 2Thomas Gerhardt,Sabine Milz,Michael Schepke,Georg Feldmann,Martin Wolff,Tilman Sauerbruch,Franz Ludwig Dumoulin.C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma[J].World Journal of Gastroenterology,2006,12(34):5495-5500. 被引量:5
  • 3De Waele B, Van NieuwenhoveY, Lauwers S, et al. Biliary tract infection in patients with acute biliary pancreatitis[J]. Sury Infect, 2003,4 (3) : 241-246.
  • 4Flores C, Maguilnik I, Hadlich E,et al. Microbiology of choledoehal bile in patients with choledocholithiasis admitted to ateriary hospital[J]. J Gastroenterol Hepatol, 2003, 18 (3): 333-336.
  • 5Hoglund C, RobertsPJ, Kuusela P, et al . Evaluati on of CA19-9 as an serum tumor marker in pancreatic cancer〔J〕. Br J Cancer, 1986; 53(2)∶197
  • 6陆雪龙 王百正 时红珍.CA19—9RIA的临床观察〔J〕[J].放射免疫学杂志,1992,5(4):222-222.
  • 7秦兴雷 石景森 王作仁等.血清和胆汁CA19—9、CEA联合检测在胆道疾病中的对比研究〔J〕[J].中华实验外科杂志,1997,:28-28.
  • 8Ohshio G, Manabe T, Watanable Y, et al. Comparative studies of DU-PAN-2,carcinoembryonic antigen, and CA19-9 in the serum and bile of patie nts with pancreaticand biliary tract disease: evaluation of the influence of ob structive jaundice 〔J〕.Am J Gastroenterol, 1990; 85(10)∶1370
  • 9Albert MB, Steinberg WM, Henry JP. Elevated serum levels of tumor m arker CA19-9 inacute cholangitis 〔J〕. Dig Dis Sci, 1988; 33(10)∶1223
  • 10Ker CG, Chen JS, Lee KT, et al. Assessment of serum and bile le vels of CA19-9 andCA125 in cholangitis and bile duct carcinoma 〔J〕. J Gastr oenterol Hepatol, 1991; 6(5)∶505

共引文献69

同被引文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部